GLP-1 Analogue and Medication Review Optimisation
Practice Pro-Forma
In response to the national shortage of GLP-1 analogues, ECLIPSE (Equality of Care Led Insights for Patient Safety & Engagement), in collaboration with your ICB and PCN, is implementing a GLP-1 and medicines optimisation project, which aims to engage with patients on GLP-1 analogues, to:
Identify those with a genuine indication or need for this class of medication.
Where indicated, to ensure that patients have adequate supply of their GLP-1 analogues.
Evaluate patients for which GLP-1s may no longer be indicated, or where they could safely move to an alternative medication.
Obtain patient consent to consider stopping or changing their GLP-1 medication.
To provide significant cost-savings to the NHS.
This pathway aims to gather important patient information around their diabetes management, empower patient-led care while safely addressing the national medication shortage.
Additionally, the CQC-accredited Putting Patient's First team will use this opportunity to conduct holistic structured medication reviews to optimise patient safety through appropriate and agreed medication changes and maximise cost-savings to the region.
Please complete the pro forma below to provide practice consent for this programme.